awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38199355-F791D993-A2AB-4FD5-B9C8-A7B3B5E888C5
Q38199355-F791D993-A2AB-4FD5-B9C8-A7B3B5E888C5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38199355-F791D993-A2AB-4FD5-B9C8-A7B3B5E888C5
How long should we treat?
P2860
Q38199355-F791D993-A2AB-4FD5-B9C8-A7B3B5E888C5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38199355-F791D993-A2AB-4FD5-B9C8-A7B3B5E888C5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1b25706c95076f734ccf4fb9f22796e3797dc75f
P2860
Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis. A randomized, double-blind, placebo-controlled trial.